The Clinical and Regulatory team at Glycomine oversees the design and implementation of clinical trials, ensures compliance with regulatory standards, and facilitates the approval process for orphan drugs targeting severe rare metabolic and protein misfolding disorders. This team plays a crucial role in progressing from preclinical development to market readiness, ensuring both safety and efficacy of the therapies.
View all